{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:09:26Z","timestamp":1792796966639,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s40266-024-01171-4","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:57:34Z","timestamp":1736333854000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring Hyperkalemia Risk in Frail Older Patients Using RAAS Inhibitors"],"prefix":"10.1007","volume":"42","author":[{"given":"Anna M. J.","family":"Heemels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine P. P. M.","family":"Gadiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angele P. M.","family":"Kerckhoffs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namiko A.","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"5","key":"1171_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"S Yusuf","year":"1991","unstructured":"Yusuf S, et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325(5):293\u2013302.","journal-title":"N Engl J Med"},{"key":"1171_CR2","doi-asserted-by":"crossref","unstructured":"CONSENSUS Trial Study Group, C.T.S., Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429\u201335.","DOI":"10.1056\/NEJM198706043162301"},{"issue":"8","key":"1171_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-136-8-200204160-00010","volume":"136","author":"G Remuzzi","year":"2002","unstructured":"Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med. 2002;136(8):604\u201315.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1171_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.ajkd.2006.10.014","volume":"49","author":"PA Sarafidis","year":"2007","unstructured":"Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis. 2007;49(1):12\u201326.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1171_CR5","first-page":"547","volume":"5","author":"SA Sadjadi","year":"2009","unstructured":"Sadjadi SA, et al. A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. Ther Clin Risk Manag. 2009;5(3):547\u201352.","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"1171_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMra035279","volume":"351","author":"BF Palmer","year":"2004","unstructured":"Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585\u201392.","journal-title":"N Engl J Med"},{"key":"1171_CR7","unstructured":"Palmer BF. Effects of aging on renal function and disease. In: Brenner & Rector's the kidney. Philadelphia: W.B. Saunders; 1996."},{"issue":"1","key":"1171_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archinte.158.1.26","volume":"158","author":"LC Reardon","year":"1998","unstructured":"Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med. 1998;158(1):26\u201332.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1171_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/archinte.1987.00370050063011","volume":"147","author":"JM Rimmer","year":"1987","unstructured":"Rimmer JM, Horn JF, Gennari FJ. Hyperkalemia as a complication of drug therapy. Arch Intern Med. 1987;147(5):867\u20139.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1171_CR10","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","volume":"30","author":"MA Raebel","year":"2012","unstructured":"Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther. 2012;30(3):e156\u201366.","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"1171_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2169\/internalmedicine.46.6415","volume":"46","author":"K Takaichi","year":"2007","unstructured":"Takaichi K, et al. Analysis of factors causing hyperkalemia. Intern Med. 2007;46(12):823\u20139.","journal-title":"Intern Med"},{"key":"1171_CR12","doi-asserted-by":"publisher","first-page":"5935149","DOI":"10.1155\/2021\/5935149","volume":"2021","author":"HR Jun","year":"2021","unstructured":"Jun HR, et al. Onset of hyperkalemia following the administration of angiotensin-converting enzyme inhibitor or angiotensin ii receptor blocker. Cardiovasc Ther. 2021;2021:5935149.","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"1171_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2215\/CJN.07821109","volume":"5","author":"MR Weir","year":"2010","unstructured":"Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010;5(3):531\u201348.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1171_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105835","volume":"172","author":"GL Hundemer","year":"2021","unstructured":"Hundemer GL, Sood MM. Hyperkalemia with RAAS inhibition: mechanism, clinical significance, and management. Pharmacol Res. 2021;172: 105835.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1171_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000013599","volume":"20","author":"TS Ahuja","year":"2000","unstructured":"Ahuja TS, et al. Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors. Am J Nephrol. 2000;20(4):268\u201372.","journal-title":"Am J Nephrol"},{"issue":"20","key":"1171_CR16","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.jacc.2007.07.067","volume":"50","author":"AS Desai","year":"2007","unstructured":"Desai AS, et al. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM program. J Am Coll Cardiol. 2007;50(20):1959\u201366.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1171_CR17","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/jgs.18343","volume":"71","author":"L Ye","year":"2023","unstructured":"Ye L, et al. The association between frailty and the risk of medication-related problems among community-dwelling older adults in Europe. J Am Geriatr Soc. 2023;71(8):2485\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"8357","key":"1171_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(83)90977-7","volume":"2","author":"FH Messerli","year":"1983","unstructured":"Messerli FH, et al. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet. 1983;2(8357):983\u20136.","journal-title":"Lancet"},{"issue":"7","key":"1171_CR19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.2215\/CJN.08611209","volume":"5","author":"F Turgut","year":"2010","unstructured":"Turgut F, Balogun RA, Abdel-Rahman EM. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations. Clin J Am Soc Nephrol. 2010;5(7):1330\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1171_CR20","unstructured":"Kompas F. farmacotherapeutisch kompas ACE-remmers. https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/groepsteksten\/ace_remmers. Cited 25 Nov 2023."},{"key":"1171_CR21","unstructured":"Kompas F. Farmacotherapeutisch kompas ARB's. https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/groepsteksten\/arb_s. Cited 25 Nov 2023."},{"key":"1171_CR22","unstructured":"Kompas F. Farmacotherapeutisch kompas renine remmers. https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/groepsteksten\/renineremmers. Cited 25 Nov 2023."},{"issue":"5","key":"1171_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489\u201395.","journal-title":"CMAJ"},{"issue":"5","key":"1171_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s41999-022-00686-6","volume":"13","author":"RS Kay","year":"2022","unstructured":"Kay RS, et al. The Clinical Frailty Scale can be used retrospectively to assess the frailty of patients with hip fracture: a validation study. Eur Geriatr Med. 2022;13(5):1101\u20137.","journal-title":"Eur Geriatr Med"},{"issue":"6","key":"1171_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s41999-020-00370-7","volume":"11","author":"K Stille","year":"2020","unstructured":"Stille K, et al. Validation of the Clinical Frailty Scale for retrospective use in acute care. Eur Geriatr Med. 2020;11(6):1009\u201315.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"1171_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13613-021-00815-7","volume":"11","author":"H Flaatten","year":"2021","unstructured":"Flaatten H, et al. Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study. Ann Intensive Care. 2021;11(1):22.","journal-title":"Ann Intensive Care"},{"issue":"12","key":"1171_CR27","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/acem.14603","volume":"29","author":"E Horlin","year":"2022","unstructured":"Horlin E, et al. Inter-rater reliability of the Clinical Frailty Scale by staff members in a Swedish emergency department setting. Acad Emerg Med. 2022;29(12):1431\u20137.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"1171_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s41999-023-00890-y","volume":"15","author":"R Albrecht","year":"2024","unstructured":"Albrecht R, et al. Clinical Frailty Scale at presentation to the emergency department: interrater reliability and use of algorithm-assisted assessment. Eur Geriatr Med. 2024;15(1):105\u201313.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"1171_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/aas.13974","volume":"66","author":"KM Fornaess","year":"2022","unstructured":"Fornaess KM, et al. Clinical frailty scale: Inter-rater reliability of retrospective scoring in emergency abdominal surgery. Acta Anaesthesiol Scand. 2022;66(1):25\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"1171_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"key":"1171_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41512-020-00074-3","volume":"4","author":"W Sauerbrei","year":"2020","unstructured":"Sauerbrei W, et al. State of the art in selection of variables and functional forms in multivariable analysis\u2014outstanding issues. Diagn Progn Res. 2020;4:3.","journal-title":"Diagn Progn Res."},{"key":"1171_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.824095","volume":"9","author":"E Riccio","year":"2022","unstructured":"Riccio E, et al. RAAS inhibitor prescription and hyperkalemia event in patients with chronic kidney disease: a single-center retrospective study. Front Cardiovasc Med. 2022;9: 824095.","journal-title":"Front Cardiovasc Med"},{"key":"1171_CR33","doi-asserted-by":"crossref","unstructured":"Bandak G, et al. Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project. J Am Heart Assoc. 2017;6(7).","DOI":"10.1161\/JAHA.116.005428"},{"issue":"1","key":"1171_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jcpt.12109","volume":"39","author":"IW Park","year":"2014","unstructured":"Park IW, et al. Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring? J Clin Pharm Ther. 2014;39(1):61\u20138.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"1171_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/pds.3748","volume":"24","author":"S Abbas","year":"2015","unstructured":"Abbas S, et al. Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor\/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort. Pharmacoepidemiol Drug Saf. 2015;24(4):406\u201313.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"1171_CR36","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00392-020-01607-y","volume":"109","author":"GCM Linssen","year":"2020","unstructured":"Linssen GCM, et al. Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF. Clin Res Cardiol. 2020;109(9):1155\u201364.","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"1171_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s40266-018-0581-z","volume":"35","author":"IM Schmidt","year":"2018","unstructured":"Schmidt IM, et al. Lower prescription rates in centenarians with heart failure and heart failure and kidney disease combined: findings from a longitudinal cohort study of very old patients. Drugs Aging. 2018;35(10):907\u201316.","journal-title":"Drugs Aging"},{"issue":"6","key":"1171_CR38","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ejhf.2483","volume":"24","author":"D Stolfo","year":"2022","unstructured":"Stolfo D, et al. Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata. Eur J Heart Fail. 2022;24(6):1047\u201362.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1171_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01171-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01171-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01171-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T15:19:07Z","timestamp":1738768747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01171-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01171-4","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"9 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Annemieke Heemels, Nadine Gadiot, Angele Kerckhoffs, and Namiko Goto declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors contributed to the study conception and design. Data collection was performed by A. Heemels and N. Gadiot. Analysis was performed by A. Heemels. The first draft of the manuscript was written by A. Heemels, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics committee of Jeroen Bosch Hospital (approval no. nw2022-19).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable since for this study only pooled anonymized data were used. Patients who have previously objected to their information being used for scientific research, by the hospital opt-out procedure, were not included.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}